Showing results (141-150 of 442) with videos related to
Sort By:
Pageof 45
Patient Preference and Adherence|October 2, 2018
Patterns and predictors of long-term retention of inflammatory bowel or rheumatoid disease patients on innovator infliximab: an analysis of a Canadian prescriptions claims databasePhilip A Baer, Guy Aumais, Emmanuel M Ewara, et al.Nature Reviews. Disease Primers|April 7, 2020
Publisher Correction: Crohn's diseaseGiulia Roda, Siew Chien Ng, Paulo Gustavo Kotze, et al.Journal of the Canadian Association of Gastroenterology|February 11, 2026
Communicating Needs and Features of IBD Experiences study: Canadian individuals and healthcare professional perceptions of the experience and impact of symptoms of moderate-to-severe ulcerative colitis and Crohn's diseaseVipul Jairath, Talat Bessissow, Jennifer Glass, et al.Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|November 21, 2012
Inflammatory bowel disease: a Canadian burden of illness reviewAngela Rocchi, Eric I Benchimol, Charles N Bernstein, et al.Nature Reviews. Disease Primers|April 4, 2020
Crohn's diseaseGiulia Roda, Siew Chien Ng, Paulo Gustavo Kotze, et al.Plos One|June 23, 2012
Up-regulation of Annexin-A1 and lipoxin A(4) in individuals with ulcerative colitis may promote mucosal homeostasisLinda Vong, Jose G P Ferraz, Neil Dufton, et al.The American Journal of Gastroenterology|July 18, 2023
P031 Impact of Prior Biologic Exposure on Response to Ozanimod for Moderate-to-Severe Ulcerative Colitis in the Phase 3 True North StudyBruce Sands, Marc Pondel, Michael Silver, et al.Journal of Crohn'S & Colitis|June 17, 2015
Clinic-based Point of Care Transabdominal Ultrasound for Monitoring Crohn's Disease: Impact on Clinical Decision MakingKerri Novak, Divine Tanyingoh, Frauke Petersen, et al.Inflammatory Bowel Diseases|December 11, 2008
Impact of ulcerative colitis from patients' and physicians' perspectives: Results from the UC: NORMAL surveyDavid T Rubin, Corey A Siegel, Sunanda V Kane, et al.Inflammatory Bowel Diseases|February 15, 2023
Upadacitinib Induction and Maintenance Therapy Improves Abdominal Pain, Bowel Urgency, and Fatigue in Patients With Ulcerative Colitis: A Post Hoc Analysis of Phase 3 DataSilvio Danese, Jacinda Tran, Geert D'Haens, et al.Pageof 45